Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study.

By M. Ortner, K. Caca, F. Berr, J. Liebetruth, U. Mansmann, D. Huster, W. Voderholzer, G. Schachschal, J. Mössner, H. Lochs. Gastroenterology, 2003

613 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

PHOTODYNAMIC THERAPY OF CANCER: AN UPDATE (2011, neutral): “In a follow-up study, 70 patients were treated, including 20 who were randomized to PDT followed by bilateral plastic stenting.(211) The median survival in the PDT plus stenting group was a remarkable 493 days compared with only 98 days in the group treated with stenting alone.”
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update (2012, background): “Photodynamic therapy In an early prospective open-label trial, 39 patients with unresectable CC were randomised to stenting alone or stenting and photodynamic therapy (PDT).(107) The PDT group had a significantly higher median survival (493 days vs 98 days).”